Literature DB >> 19086588

Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients.

A Masoudzadeh1, A R Khalilian.   

Abstract

The aim of this study was to compare the results of treatment with clozapine alone, Electroshock (ECT) alone and the combination of clozapine with ECT in treatment-resistant schizophrenic patients. Eighteen treatment-resistant schizophrenic patients were assigned to three equal groups: one group was given clozapine; one group was treated with ECT and one group was treated with the combination of clozapine and ECT. The treatment response was evaluated using the PANSS criteria and the data were analyzed with ANOVA. Combination therapy was superior to single modality therapy. The reduction of PANSS scores was 46% in the clozapine group, 40% in the ECT groups and 71% in the combination group, the difference between the combination group and the other groups was statistically significant (p < 0.05). Patients had a quick response to combination treatment, which resulted in a higher cure rate of positive and negative symptoms and improved the patients general performance. There were no significant adverse effects with combination treatment. Combination treatment with clozapine and ECT was safe and effective in treatment-resistant schizophrenic patients. It should be considered for the treatment of treatment-resistant schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19086588     DOI: 10.3923/pjbs.2007.4287.4290

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  16 in total

1.  Neuromodulation Treatments for Schizophrenia.

Authors:  Mehmet E Dokucu
Journal:  Curr Treat Options Psychiatry       Date:  2015-07-03

2.  Searching for the mechanism(s) of ECT's therapeutic effect.

Authors:  W Vaughn McCall; Chittaranjan Andrade; Pascal Sienaert
Journal:  J ECT       Date:  2014-06       Impact factor: 3.635

3.  Combined Antipsychotics and Electroconvulsive Therapy in an Acutely Psychotic Patient with Treatment-resistant Schizophrenia.

Authors:  Ruth Rayikanti; Iga Lentowicz; Badari Birur; Li Li
Journal:  Psychopharmacol Bull       Date:  2017-05-15

Review 4.  Electroconvulsive Therapy and Schizophrenia: A Systematic Review.

Authors:  Sana A Ali; Nandita Mathur; Anil K Malhotra; Raphael J Braga
Journal:  Mol Neuropsychiatry       Date:  2019-04-02

Review 5.  Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.

Authors:  Frederick C Nucifora; Edgar Woznica; Brian J Lee; Nicola Cascella; Akira Sawa
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

6.  Remission of Psychosis in Treatment-resistant Schizophrenia Following a Seizure: A Case Report.

Authors:  Hena Jawaid; Sana Younus; Hanif Mesiya
Journal:  Innov Clin Neurosci       Date:  2016-06-01

7.  Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".

Authors: 
Journal:  Neuropsychopharmacol Rep       Date:  2021-08-12

8.  Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial.

Authors:  Biswa Ranjan Mishra; Kanhaiyalal Agrawal; Tathagata Biswas; Debadatta Mohapatra; Santanu Nath; Rituparna Maiti
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

9.  Combined clozapine and electroconvulsive therapy in a Japanese schizophrenia patient: a case report.

Authors:  Yuta Yoshino; Yuki Ozaki; Koichiro Kawasoe; Shinichiro Ochi; Takanori Niiya; Naomi Sonobe; Teruhisa Matsumoto; Shu-Ichi Ueno
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-08-12       Impact factor: 2.582

10.  Delayed onset, protracted delirium and aspiration pneumonitis associated with a combination of clozapine and electroconvulsive therapy.

Authors:  N Manjunatha; G S Ram Kumar; R Vidyendaran; K Muralidharan; J P John
Journal:  Indian J Psychol Med       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.